Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

COEP Coeptis Therapeutics Holdings Inc

5,29

-0,62 (-10,49%)

04 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Trading Halt Occurred During This Micro Cap's EOY Surge

It has been surprisingly quiet for the last day of the year in a handful of sectors, however that is not the case for a certain Pennsylvania-based biotech. While on no specific...

To read the full story on AllPennyStocks.com, click here.

Coeptis Therapeutics (NASDAQ:COEP)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Coeptis Therapeutics Charts.

Coeptis Therapeutics (NASDAQ:COEP)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Coeptis Therapeutics Charts.

News Coeptis Therapeutics Holdings Inc

Trading Halt Occurred During This Micro Cap's EOY Surge
Dienstag 31 Dezember 2024 (4 Tage vor) • AllPennyStocks.com

Coeptis Therapeutics Announces Reverse Stock Split
Freitag 27 Dezember 2024 (1 Woche vor) • PR Newswire (US)

Coeptis Therapeutics Makes Bold Strides in Innovation with the Acquisition of NexGenAI Affiliates Network Platform and Launch of Coeptis Technologies
Donnerstag 26 Dezember 2024 (1 Woche vor) • PR Newswire (US)

Coeptis Therapeutics Unveils New Technology Division: Coeptis Technologies
Donnerstag 12 Dezember 2024 (3 Wochen vor) • PR Newswire (US)

Coeptis Therapeutics Executes Binding Letter of Intent to Acquire Ai-powered Marketing Solutions for Biotech, Pharmaceutical and Other Industries
Dienstag 3 Dezember 2024 (1 Monat vor) • PR Newswire (US)

Coeptis Therapeutics Announces Phase 1 Data on DVX201 for COVID-19 Treatment Has Been Accepted for Publication in Molecular Therapy Methods and Clinical Development
Donnerstag 7 November 2024 (2 Monate vor) • PR Newswire (US)

Coeptis Therapeutics Expands License Agreement with Deverra to Include Pandemic Preparedness, and Emergency Use
Donnerstag 24 Oktober 2024 (2 Monate vor) • PR Newswire (US)

Coeptis Therapeutics' Chief Scientific and Medical Officer to Present at Upcoming Fall Conferences, Highlighting Progress in Universal Cell Therapy
Dienstag 15 Oktober 2024 (3 Monate vor) • PR Newswire (US)

Coeptis Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing
Donnerstag 19 September 2024 (4 Monate vor) • PR Newswire (US)

Coeptis Therapeutics Chief Executive Officer, Dave Mehalick, Updates and Outlines Strategic Vision in Letter to Shareholders
Donnerstag 5 September 2024 (4 Monate vor) • PR Newswire (US)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Freitag 16 August 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Freitag 16 August 2024 (5 Monate vor) • Edgar (US Regulatory)

Weitere Coeptis Therapeutics Holdings Inc News-Artikel

Financial Select Sector

Energy Select Sector SPDR

BNP Paribas (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen